• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一项比较单倍体相合供者移植与脐带血移植和 HLA 匹配同胞供者移植治疗血液系统恶性肿瘤患者的前瞻性试验。

A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients.

机构信息

Department of Hematology, Tianjin First Central Hospital, Tianjin, PR China.

Nankai University Affiliated First Central Hospital, Tianjin, PR China.

出版信息

Cell Transplant. 2022 Jan-Dec;31:9636897221076050. doi: 10.1177/09636897221076050.

DOI:10.1177/09636897221076050
PMID:35168385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8855410/
Abstract

Effect of co-infusion third party umbilical cord blood stem cells on haploidentical hematopoietic stem cell transplantation https://www.chictr.org.cn Reg. No. ChiCTR-OIN-17011426.

摘要

第三方脐血干细胞共输注对单倍体造血干细胞移植的影响 [www.chictr.org.cn 注册号 ChiCTR-OIN-17011426]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b6/8855410/63d44079caf7/10.1177_09636897221076050-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b6/8855410/40748bffcc11/10.1177_09636897221076050-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b6/8855410/8e43b861abd5/10.1177_09636897221076050-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b6/8855410/784cf8a025e3/10.1177_09636897221076050-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b6/8855410/2a89ef7b2a7e/10.1177_09636897221076050-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b6/8855410/63d44079caf7/10.1177_09636897221076050-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b6/8855410/40748bffcc11/10.1177_09636897221076050-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b6/8855410/8e43b861abd5/10.1177_09636897221076050-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b6/8855410/784cf8a025e3/10.1177_09636897221076050-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b6/8855410/2a89ef7b2a7e/10.1177_09636897221076050-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b6/8855410/63d44079caf7/10.1177_09636897221076050-fig5.jpg

相似文献

1
A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients.一项比较单倍体相合供者移植与脐带血移植和 HLA 匹配同胞供者移植治疗血液系统恶性肿瘤患者的前瞻性试验。
Cell Transplant. 2022 Jan-Dec;31:9636897221076050. doi: 10.1177/09636897221076050.
2
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.非洲裔美国血液系统恶性肿瘤患者的最佳供者：HLA单倍型相合亲属或脐带血移植
Biol Blood Marrow Transplant. 2020 Oct;26(10):1930-1936. doi: 10.1016/j.bbmt.2020.06.029. Epub 2020 Jul 7.
3
Haploidentical transplants deliver equal outcomes to matched sibling transplants: a propensity score-matched analysis.单倍体相合移植与同胞相合移植疗效相当：倾向评分匹配分析。
J Transl Med. 2023 May 18;21(1):329. doi: 10.1186/s12967-023-04168-6.
4
Cord blood versus haploidentical stem cell transplantation for hematological malignancies.脐带血与单倍体干细胞移植治疗血液系统恶性肿瘤
Semin Hematol. 2016 Apr;53(2):98-102. doi: 10.1053/j.seminhematol.2016.01.007. Epub 2016 Jan 15.
5
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.来自HLA匹配供者和替代供者的异基因造血干细胞移植的结局：欧洲血液与骨髓移植学会登记处的回顾性分析
Lancet Haematol. 2019 Nov;6(11):e573-e584. doi: 10.1016/S2352-3026(19)30158-9. Epub 2019 Aug 30.
6
T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.采用移植后环磷酰胺的 T 细胞富含 HLA 单倍体相合造血移植治疗血液系统恶性肿瘤可获得与同期 HLA 匹配的亲缘和无关供者移植相当的结果。
J Clin Oncol. 2013 Apr 1;31(10):1310-6. doi: 10.1200/JCO.2012.44.3523. Epub 2013 Feb 19.
7
Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies.前瞻性随机研究比较了清髓性非亲缘脐带血移植与 HLA 单倍体相合亲缘干细胞移植治疗血液系统恶性肿瘤成人患者的效果。
Biol Blood Marrow Transplant. 2020 Feb;26(2):358-366. doi: 10.1016/j.bbmt.2019.10.014. Epub 2019 Oct 23.
8
Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation.单倍型相合造血干细胞移植后的死亡原因及其与人类白细胞抗原（HLA）相合同胞造血干细胞移植的比较。
Bone Marrow Transplant. 2016 Mar;51(3):391-7. doi: 10.1038/bmt.2015.306. Epub 2015 Dec 21.
9
Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.与其他替代供体和匹配的同胞移植物相比，未处理的单倍体同基因移植。
Biol Blood Marrow Transplant. 2014 Oct;20(10):1573-9. doi: 10.1016/j.bbmt.2014.05.029. Epub 2014 Jun 5.
10
Low usage rate of banked sibling cord blood units in hematopoietic stem cell transplantation for children with hematological malignancies: implications for directed cord blood banking policies.在儿童血液系统恶性肿瘤的造血干细胞移植中，脐带血库中保存的同胞脐带血使用率低：对定向脐带血库存储政策的启示。
Blood Cells Mol Dis. 2011 Feb 15;46(2):177-81. doi: 10.1016/j.bcmd.2010.10.017. Epub 2010 Nov 20.

引用本文的文献

1
[Haploidentical donor peripheral blood stem cell transplantation using third-party cord blood compared with matched unrelated donor transplantation for patients with hematologic malignancies].[采用第三方脐血的单倍体相合供者外周血干细胞移植与血液系统恶性肿瘤患者的匹配无关供者移植的比较]
Zhonghua Xue Ye Xue Za Zhi. 2024 Feb 14;45(2):141-147. doi: 10.3760/cma.j.cn121090-20230928-00149.
2
Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients.第三方脐血支持的单倍型相合外周血干细胞移植与人类白细胞抗原匹配的同胞外周血干细胞移植在血液系统恶性肿瘤患者中的疗效比较
Front Oncol. 2022 Jul 14;12:922120. doi: 10.3389/fonc.2022.922120. eCollection 2022.

本文引用的文献

1
Haploidentical related donor vs matched sibling donor allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome aged over 50 years: A single-center retrospective study.50 岁以上急性髓系白血病和骨髓增生异常综合征患者接受单倍体相合相关供者与同胞相合供者异基因造血干细胞移植的单中心回顾性研究。
Cancer Med. 2020 Sep;9(17):6244-6255. doi: 10.1002/cam4.3290. Epub 2020 Jul 20.
2
Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin.双份脐血移植联合未经抗胸腺细胞球蛋白的单倍体相合 CD34+细胞后的植入动力学。
Leukemia. 2021 Mar;35(3):850-862. doi: 10.1038/s41375-020-0922-x. Epub 2020 Jun 18.
3
Combination of haploidentical haematopoietic stem cell transplantation with an unrelated cord-blood unit in patients with severe aplastic anemia: a report of 146 cases.
在重型再生障碍性贫血患者中采用单倍体相合造血干细胞移植联合无关脐带血单位治疗：146 例报告。
Bone Marrow Transplant. 2020 Oct;55(10):2017-2025. doi: 10.1038/s41409-020-0874-9. Epub 2020 Mar 26.
4
Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data.在序贯强化预处理后接受 DLI 的难治性急性白血病中，与 HLA 匹配的同胞供者移植相比，单倍体相合移植：来自两项前瞻性数据的分析。
J Hematol Oncol. 2020 Mar 12;13(1):18. doi: 10.1186/s13045-020-00859-5.
5
Combining haplo-identical and cord blood stem cell grafts - might the whole be greater than the sum of its parts?联合单倍体相合与脐血干细胞移植——整体是否可能大于部分之和？
Leuk Lymphoma. 2020 Apr;61(4):753-756. doi: 10.1080/10428194.2020.1725509. Epub 2020 Feb 12.
6
Comparison of outcomes of haploidentical donor hematopoietic stem cell transplantation supported by third-party cord blood with HLA-matched unrelated donor transplantation.第三方脐带血支持下的单倍体相合供者造血干细胞移植与 HLA 匹配的无关供者移植的结局比较。
Leuk Lymphoma. 2020 Apr;61(4):840-847. doi: 10.1080/10428194.2019.1695053. Epub 2019 Nov 28.
7
Haploidentical stem cells combined with a small dose of umbilical cord blood transplantation exert similar survival outcome of HLA-matched stem cells transplantation in T-cell acute lymphoblastic leukemia.单倍体相合干细胞联合小剂量脐带血移植在T细胞急性淋巴细胞白血病中的生存结果与HLA匹配的干细胞移植相似。
Bone Marrow Transplant. 2020 Jun;55(6):1197-1199. doi: 10.1038/s41409-019-0666-2. Epub 2019 Sep 5.
8
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.来自HLA匹配供者和替代供者的异基因造血干细胞移植的结局：欧洲血液与骨髓移植学会登记处的回顾性分析
Lancet Haematol. 2019 Nov;6(11):e573-e584. doi: 10.1016/S2352-3026(19)30158-9. Epub 2019 Aug 30.
9
Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning.成人患者接受氟达拉滨和马法兰预处理后行haploidentical 与haplo-cord 移植的比较。
Blood Adv. 2019 Jun 25;3(12):1858-1867. doi: 10.1182/bloodadvances.2019000200.
10
Comparison of outcomes in hematological malignancies treated with haploidentical or HLA-identical sibling hematopoietic stem cell transplantation following myeloablative conditioning: A meta-analysis.清髓性预处理后单倍体相合或 HLA 全相合同胞造血干细胞移植治疗血液系统恶性肿瘤的疗效比较：一项荟萃分析。
PLoS One. 2018 Jan 30;13(1):e0191955. doi: 10.1371/journal.pone.0191955. eCollection 2018.